VOYA Investment Management
GLUE icon

VOYA Investment Management’s Monte Rosa Therapeutics GLUE Stock Holding History

VOYA Investment Management’s Portfolio GLUE Stock Details GLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.79M Buy
156,633
+74,294
+90% +$1.4M ﹤0.01% 981
2026
Q1 		$1.35M Buy
82,339
+55,957
+212% +$1.07M ﹤0.01% 1351
2025
Q4 		$414K Buy
+26,382
New +$356K ﹤0.01% 1839
2025
Q3 		– Sell
-12,958
Closed -$58.4K – 2527
2025
Q2 		$58.4K Buy
12,958
+1,345
+12% +$6K ﹤0.01% 2575
2025
Q1 		$53.9K Sell
11,613
-552
-5% -$3.38K ﹤0.01% 2535
2024
Q4 		$84.4K Sell
12,165
-957
-7% -$7.18K ﹤0.01% 2610
2024
Q3 		$69.5K Buy
13,122
+1,969
+18% +$9.94K ﹤0.01% 2728
2024
Q2 		$41.7K Buy
11,153
+595
+6% +$3.03K ﹤0.01% 2803
2024
Q1 		$74.4K Sell
10,558
-1,907
-15% -$11.3K ﹤0.01% 2677
2023
Q4 		$70.4K Sell
12,465
-80,365
-87% -$315K ﹤0.01% 2817
2023
Q3 		$445K Hold
92,830
– – ﹤0.01% 2100
2023
Q2 		$636K Buy
92,830
+502
+0.5% +$3.25K ﹤0.01% 1945
2023
Q1 		$719K Hold
92,328
– – ﹤0.01% 1836
2022
Q4 		$703K Sell
92,328
-6,874
-7% -$57.3K ﹤0.01% 1832
2022
Q3 		$810K Buy
99,202
+88,772
+851% +$815K ﹤0.01% 1742
2022
Q2 		$101K Buy
+10,430
New +$105K ﹤0.01% 2615
2022
Q1 		– Sell
-95,355
Closed -$1.95M – 2694
2021
Q4 		$1.95M Sell
95,355
-7,466
-7% -$156K ﹤0.01% 1165
2021
Q3 		$2.29M Sell
102,821
-1,356
-1% -$38.9K ﹤0.01% 1113
2021
Q2 		$2.36M Buy
+104,177
New +$2.12M ﹤0.01% 1130

Other funds holding GLUE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VOYA Investment Management's GLUE Position: Q2 2026 in Review

VOYA Investment Management increased its Monte Rosa Therapeutics (GLUE) stake by 90% in Q2 2026, buying an estimated $1.4M and bringing the position to 156,633 shares worth $3.79M. The position accounts for ﹤0.01% of the portfolio, ranked #981.

VOYA Investment Management first reported a position in GLUE in Q2 2021 and has held it in 19 quarters since. 193 funds tracked by Wall St. Rank hold GLUE as of Q2 2026.

  • VOYA Investment Management held 156,633 shares of Monte Rosa Therapeutics worth $3.79M as of Q2 2026.
  • VOYA Investment Management bought 74,294 Monte Rosa Therapeutics shares in Q2 2026, an estimated $1.4M.
  • Monte Rosa Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #981 holding.
  • VOYA Investment Management first reported a position in Monte Rosa Therapeutics in Q2 2021 and has held it in 19 quarters since.
  • 193 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.